Bram Goorden
Vermögen: 376 289 $ am 31.10.2026
Vermögen: 376 289 $ am 31.10.2026
Bram Goorden is Chief Executive Officer & Director at Ixico Plc since 2024.
Mr. Goorden is Chairman at Mantis Photonics AB. Mr. Goorden is Director at Oncobit AG.
Mr. Goorden is Non-Executive Director at Zetta Genomics Ltd. since 2024.
Former roles include Director at Cerecin, Inc., Vice President-International Business at Foundation Medicine, Inc. from 2018 to 2020, Chief Operating Officer & Senior Vice President at SOPHiA GENETICS SA from 2020 to 2022, and General Manager & Head-Therapeutics at Prometheus Labs, Inc. from 2016 to 2018.
Education includes undergraduate studies at Alma Mater Studiorum - Università di Bologna and graduate studies at the University of Antwerp.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IXICO PLC 1,09 % | 18.06.2026 | 2.390.501 ( 1,09 % ) | 376 289 $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IXICO PLC | Vorstandsvorsitzender | 19.08.2024 |
Mantis Photonics AB
Mantis Photonics AB Packaged SoftwareTechnology Services Develops AI software to detect disease markers | Vorsitzender | - |
Zetta Genomics Ltd.
Zetta Genomics Ltd. Data Processing ServicesTechnology Services Provides healthcare data management services | Direktor/Vorstandsmitglied | 27.09.2024 |
Oncobit AG
Oncobit AG Internet Software/ServicesTechnology Services Operates as a monitoring platform | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| SOPHIA GENETICS SA | Geschäftsführer | 31.05.2022 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01.01.2020 |
Prometheus Labs, Inc.
Prometheus Labs, Inc. Other Consumer ServicesConsumer Services Provides long term valet parking services | Corporate Officer/Principal | 01.01.2018 |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Health Technology |
Ixico Plc
Ixico Plc Miscellaneous Commercial ServicesCommercial Services Operates as a medical imaging company that provides imaging biomarkers for clinical trials, research studies and diagnostics | Commercial Services |
Alma Mater Studiorum - Università di Bologna
Alma Mater Studiorum - Università di Bologna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
University of Antwerp
University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SOPHiA GENETICS SA
SOPHiA GENETICS SA Packaged SoftwareTechnology Services Develops software services for healthcare industry | Technology Services |
Prometheus Labs, Inc.
Prometheus Labs, Inc. Other Consumer ServicesConsumer Services Provides long term valet parking services | Consumer Services |
Oncobit AG
Oncobit AG Internet Software/ServicesTechnology Services Operates as a monitoring platform | Technology Services |
Zetta Genomics Ltd.
Zetta Genomics Ltd. Data Processing ServicesTechnology Services Provides healthcare data management services | Technology Services |
Mantis Photonics AB
Mantis Photonics AB Packaged SoftwareTechnology Services Develops AI software to detect disease markers | Technology Services |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen